Hydroxamic acid compounds
US6063816A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Aug 9, 1999 |
| Grant date | May 16, 2000 |
| Priority date | — |
| Expiry date | Aug 9, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound selected from those of formula (I): ##STR1## wherein: R.sub.1 represents optionally substituted alkyl, acyl, cycloalkyl, aryl, aminocarbonylalkyl, or heterocycle, PA1 R.sub.2 represents alkylene, PA1 R.sub.3 represents X or Y as defined in the description, PA1 R.sub.4 represents--either alkyl, cycloalkyl, aryl, arylalkyl, cycloalkylalkyl, heterocycloalkylene, or heterocycle when R.sub.3 represents Y, PA1 or biaryl, arylheteroaryl or heteroarylaryl, when R.sub.3 represents X or Y, their isomers and also pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same which are useful as metalloprotease inhibitors in the treatment of cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.